• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Adverse In-Hospital Outcomes According to Pelvic Lymph Node Dissection at Partial Cystectomy.

作者信息

Marmiroli Andrea, Longoni Mattia, Le Quynh Chi, Falkenbach Fabian, Nicolazzini Michele, Catanzaro Calogero, Polverino Federico, Goyal Jordan A, Luzzago Stefano, Mistretta Francesco Alessandro, Piccinelli Mattia, Saad Fred, Shariat Shahrokh F, Briganti Alberto, Chun Felix K H, Graefen Markus, Palumbo Carlotta, Schiavina Riccardo, Longo Nicola, Musi Gennaro, Karakiewicz Pierre I

机构信息

Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.

Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.

出版信息

Ann Surg Oncol. 2025 Aug 16. doi: 10.1245/s10434-025-18072-4.

DOI:10.1245/s10434-025-18072-4
PMID:40819147
Abstract
摘要

相似文献

1
ASO Author Reflections: Adverse In-Hospital Outcomes According to Pelvic Lymph Node Dissection at Partial Cystectomy.ASO作者反思：部分膀胱切除术时盆腔淋巴结清扫术后的院内不良结局
Ann Surg Oncol. 2025 Aug 16. doi: 10.1245/s10434-025-18072-4.
2
Adverse In-hospital Outcomes According to Pelvic Lymph Node Dissection at Partial Cystectomy.部分膀胱切除术中盆腔淋巴结清扫术后的院内不良结局
Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17841-5.
3
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.医院和手术量是膀胱癌综合治疗的预测因素：基于人群的研究。
J Urol. 2011 Sep;186(3):824-8. doi: 10.1016/j.juro.2011.04.066. Epub 2011 Jul 23.
4
The Influence of Access Related Factors on Adherence to Clinical Practice Guidelines for Muscle Invasive Bladder Cancer.与就诊相关因素对肌层浸润性膀胱癌临床实践指南依从性的影响
Urol Pract. 2014 Sep;1(3):127-133. doi: 10.1016/j.urpr.2014.05.004. Epub 2014 Jun 23.
5
The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.淋巴结清扫术及淋巴结转移对膀胱癌根治性膀胱切除术预后的影响。
Eur Urol. 2009 Apr;55(4):826-35. doi: 10.1016/j.eururo.2009.01.004. Epub 2009 Jan 13.
6
Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.机器人辅助根治性膀胱切除术的肿瘤学和功能结局的系统评价和累积分析。
Eur Urol. 2015 Mar;67(3):402-22. doi: 10.1016/j.eururo.2014.12.008. Epub 2015 Jan 2.
7
Effect of Pembrolizumab on Lymph Node Dissection in Patients Who Experienced Bladder Cancer Recurrence Following Radical Cystectomy.帕博利珠单抗对根治性膀胱切除术后膀胱癌复发患者淋巴结清扫的影响。
In Vivo. 2025 Jul-Aug;39(4):2196-2208. doi: 10.21873/invivo.14015.
8
Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies.根治性膀胱切除术治疗膀胱癌患者中扩展与非扩展盆腔淋巴结清扫术及其对无复发生存率的影响：系统评价和比较研究的荟萃分析。
BJU Int. 2014 May;113(5b):E39-48. doi: 10.1111/bju.12371.
9
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术：仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.
10
Pelvic lymph-node dissections in bladder and prostate cancer surgery and the risk of postoperative venous thromboembolism.膀胱癌和前列腺癌手术中的盆腔淋巴结清扫术与术后静脉血栓栓塞风险
Eur J Surg Oncol. 2025 Oct;51(10):110326. doi: 10.1016/j.ejso.2025.110326. Epub 2025 Jul 14.

本文引用的文献

1
Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in T2N0M0 Urothelial Bladder Cancer.T2N0M0期尿路上皮膀胱癌行部分膀胱切除术与根治性膀胱切除术的癌症特异性死亡率
Ann Surg Oncol. 2025 May 27. doi: 10.1245/s10434-025-17488-2.
2
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.NCCN 指南®洞察：膀胱癌，第 3.2024 版。
J Natl Compr Canc Netw. 2024 May;22(4):216-225. doi: 10.6004/jnccn.2024.0024.
3
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
膀胱非转移性 T2-T3 期尿路上皮癌行部分膀胱切除术加盆腔淋巴结清扫术患者：时间趋势和生存结果。
Clin Genitourin Cancer. 2020 Apr;18(2):129-137.e3. doi: 10.1016/j.clgc.2019.09.008. Epub 2019 Sep 26.
4
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.根治性膀胱切除术治疗膀胱癌患者的广泛淋巴结清扫与局限性淋巴结清扫的比较：一项前瞻性随机试验的生存结果。
Eur Urol. 2019 Apr;75(4):604-611. doi: 10.1016/j.eururo.2018.09.047. Epub 2018 Oct 15.